Jump to content

User talk:104.10.252.226

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

In the criticism of HY Wang conducting biomarker analysis of Phase II CSF samples, it should be noted that he was and still is blind to treatment group. Any conflicts cannot overcome being blind to group.

Welcome to this talk page

Start a discussion